SlideShare a Scribd company logo
Common Heart Conditons in
Children
Presenters:
• Aqim
• Analicia
CONGENITAL
HEART DISEASES
CONTENTS
Fetal Circulation
Congenital Heart Diseases (CHD)
Incidence
Mortality and Morbidity
 Etiological Factors
Classification of CHD
Cyanotic
Acyanotic
Hemodynamics of Common CHD
Assessment & Management
Dr.Nidhi Ahya(Asst Prof)
Fetal Circulation
Blood from
placenta
Inferior Vena
Cava
RightAtrium
Left atrium
via Foramen
Ovale
Left ventricle
Aorta Head & Neck
Returns via
Superior
Vena Cava
RightAtrium
Right
Ventricle
Pulmonary
Artery
Aorta via
Patent Ductus
Arteriosus
Lower
Extremities
Blood to
Placenta
CONGENITAL HEART DISEASES
(CHD) These are cardiac anomalies
arising as a result of a defect in
the structure or function of
the heart and great vessels which
is present at birth
These lesions either
obstruct blood flow in the heart
or vessels near it, or alter the
pathway of blood
circulating through the heart
CLASSIFICATION OF
CHD
ACYNOTIC
Volume or
Pressure
Overload
PDA, VSD,ASD,
Coartation ofAorta
PINK
BABY
CYNOTIC
OR
Pulmonary
Blood flow
Tetralogy of Fallot,
Transposition of
great vessels,
TricuspidAtresia
BLUE
BABY
Atrial Septal Defect
(ASD)  An abnormal opening in the atrial
septum which allows oxygenated
blood from the left atrium to mix
with deoxygenated blood in the right
atrium at a minor pressure
difference
 Right atrium recieves blood from
SVC,IVC as well as from left atrium
leading to volume overload and
pulmonary congestion
 Occurs in about 4-10% of CHD
 More common in female child
Types of ASD:
 Ostium Secundum
most common- 50-70%,
In the middle of the septum in
the region of the foramen
ovale
 Ostium primum
30% -Low position
Form of AV septal defect
 Sinus venosus
Least common-10%
Site-at entry of superior
venacava into right atrium
Clinical Presentation:
Most infants and children are asymptomatic but over
years to decades may experience the symptoms
depending on type and severity of ASD
 Infant gets tired during feeding
 Child gets tired with playing/eating
 Shortness of breath
 Fatigue
 Sweating
Palpitations
Stunted growth
Diagnosis:
On Auscultation-
S1 :normal
S2: Widely split & fixed with P2 accentuated
 Ejection systolic murmur is present
 Chest X-ray - Mild to moderate cardiomegaly
with enlarged right atrium & right ventricle,
prominent pulmonary artery segment,
increased pulmonary vascular markings
Dr.Nidhi Ahya(Asst Prof)
 ECG- Right Axis Deviation, Right ventricular strain
pattern in lead V1
 Echocardiogram- position, size, signs of LR
shunt, flow
Management:
 20% of atrial septal defects will close spontaneously
in the first year of life or as the child grows
 For defects of 3-8mm, or smaller, supportive
medical management – Digoxin, diuretics and
prophylactic antibiotics are sufficient up till
spontaneous closure
 If defect is >8mm, surgical repair may
be is required
 If spontaneous closure does not
occur by school- going age,
surgical repair becomes essential
to prevent lung problems that will
develop from long- time exposure
to extra blood flow
 Surgical repair
Ventricular Septal Defect
(VSD)  An abnormal opening in the
ventricular septum which allows
oxygenated blood from the left
ventricle to mix with deoxygenated
blood in the right ventricle
 Right ventricle recieves blood from
right atrium as well as from left
ventricle leading to volume overload
and pulmonary congestion
 VSDs are the most commonly
occurring type of congenital heart
defect, occurring in 14-17 % of babies
born each year
Dr.Nidhi Ahya(Asst Prof) 16
Types of VSD:
 Supracristal VSD
occurs just beneath the
aortic valve at the left
ventricular outflow tract
 Membranous VSD
The most common type
and originate inferior to
the crista
supraventricularis
 Muscular VSD
Occur in the mid to apical
interventricular septum
Clinical Presentation:
 Signs and symptoms vary with the size of the
defect.
 Clinical symptoms are usually not seen at birth
because of continued high pulmonary vascular
resistance in the newborn
 Infants with moderate to large defects will become
symptomatic within the first few weeks of life.
Shortness of breath while feeding
Poor growth
Failure to gain weight
Pounding Heart
Frequent respiratory tract infections
shunt occurs- cynosis, clubbing,
If reversal of
respiratory distress
Diagnosis:
 On Auscultation-
Pansystolic murmur is present
S1 is masked by the murmur
S3 can be heard at the apex
Chest X-ray- Cardiomegaly and incresed pulmonary
vascular markings
Management :
 Medical management
 digoxin
Diuretics
 Adequate nutrition
high-calorie formula or breast milk
supplemental tube feedings
Prophylactic antibiotics to prevent bacterial
endocarditis
 Surgical repair – closed stitches
or special patch
 Interventional cardiac
catheterization – Septal occluder
 Outcome of Surgery- 95%
success rate, growth of child
catches up in 1-2 years, size of
the heart reduces, murmurs can
be heard 2-3 months post-
operative also but hold very little
clinical importance
Patent Ductus Arteriosis
(PDA)
 Failure of closure of ductus
arteriosus
 Incidence: Mostly in premature
infants or infants born to a mother
who had rubella during the first
trimester of pregnancy
 Through the PDA -> oxygenated
blood passes from the aorta to the
pulmonary artery & mixes with the
deoxygenated blood which goes to
the lungs -> Increased blood
volume to the lungs -> pulmonary
hypertension and congestion
Dr.Nidhi Ahya(Asst Prof)
 As blood is pumped at high pressure through the
PDA, the lining of the pulmonary artery will
become irritated and inflamed. Bacteria in the
bloodstream can easily infect this injured area
bacterial endocarditis
Clinical Presentation:
 Shortness of breath
 Congested breathing
 Disinterest in feeding, or tiring while feeding
 Poor weight gain
 Sweating
 Tachypnea
 Bounding pulse
Diagnosis:
 On Auscultation-
Continuous machinery murmur in the left
infraclavicular region
 Management:
Medical Management
•Indomethacin IV (prostaglandin inhibitor) may
help close a PDA. It works by stimulating the
muscles inside the PDA to constrict, thereby
closing the connection
•Digoxin
•Diuretics
Adequate nutrition
• High-calorie formula or breast milk
•Special nutritional supplements may be added to
formula or pumped breast milk that increase the
number of calories in each ounce
Surgical Management
•Repair is usually indicated in infants younger than 6
months of age who have large defects that are
causing symptoms, such as poor weight gain and
rapid breathing
 Transcatheter coil closure of the PDA
PDA ligation-involves closing the open PDAwith
stitches or the vessel connecting the aorta and
pulmonary artery may be cut and cauterized
CYNOTIC HEART DISEASE
These type of defects lead to either
increased or decreased pulmonary
blood flow
The primary pathology arises either
due to an obstructive lesion; or due to
abnormal anatomy or both
The shunt present is predominantly
from Right to Left leading to shunting of
venous blood without passing through
the lungs to be oxygenated
Unoxygenated blood circulates in
arteries - > cyanosis
Example: Tetralogy of Fallot,TGV
Tetralogy of Fallot (TOF)
 A complex condition of several
congenital defects that occur due to
abnormal devlopment of the fetal
heart during the first 8 weeks of
pregnancy
 ‘Tetra’ meaning ‘four’
Ventricular septal defect (VSD)
Pulmonary valve stenosis
Overriding aorta
Right ventricular hypertrophy
 Due to pulmonary artery stenosis, RV has to work
harder to push blood into the lungs, thereby
increasing the RV pressure and size
 Presence of VSD facilitates blood to pass from the
RV into the left ventricle, and mixing of blood takes
place.
 Overriding of aorta- The aorta sits above both the
left and right ventricles over the VSD, rather than
just over the left ventricle. As a result, oxygen poor
blood from the right ventricle can flow directly into
the aorta instead of into the pulmonary artery to the
lungs
 Decresed pulmonary blood flow and poorly
oxygenated blood circulating throughout the body
leads to CYNOSIS
Clinical Presentation:
Cyanosis - (bluish color of the skin, lips, and nail
beds) that occurs with such activity as crying or
feeding
 Irritability
 Lethargic
 Reduced physical activity
 Fainting
 Clubbing of nails of fingers/toes
 Breathing difficulty
Diagnosis:
On Auscultation- An ejection systolic murmur is
present at the Left parasternal region 3rd ICS due
to pulmonary stenosis.
Investigations
Chest radiograph
• Boot shaped heart
• Unturned apex
• Pulmonary artery bay
• Oligemic lung fields
• Enlarged aorta
Investigations
• ECG
• RVH (p-pulmonale (Right atrium),
tall R waves in V1, upright T wave
in V1.
• Marked right axis deviation
• Echo
• Detection of main features
• Quantification of right ventricular
outflow pressure gradient
• May be performed with cardiac
catheterization
Management :
 Requires surgical repair usually undertaken at 6-18
months age
 It involves- closure of VSD with a tangential patch
to correct the override and the pulmonary stenosis
is relieved with a patch).
Transposition of Great Vessels
(TOG)  The aorta is connected to the right
ventricle, and the pulmonary artery is
connected to the left ventricle
 Oxygen-poor (blue) blood returns to
the right atrium from the body - >
passes through the right atrium and
ventricle, -> into the misconnected
aorta back to the body.
 Oxygen-rich (red) blood returns to the
left atrium from the lungs - > passes
through the left atrium and ventricle, ->
into the pulmonary artery and back to
the lungs.
Clinical Presentation:
Cyanosis - (bluish color of the skin, lips, and nail
beds) that occurs with such activity as crying or
feeding
 Rapid and laboured breathing
 Cold and clammy skin
Failure to thrive
Investigations
• Echocardiography
(confirmatory)
• Chest radiograph
1. Egg on a string heart
2. Increased pulmonary
vascular markings
• ECG : normal
Management:
 Admitted to NICU
 On ventilator support
 Cardiac Catheterization
 Ballon Atrial Septostomy
 I.v. Prostaglandins administered
 By 2nd week of life, TGA repair
is done
 ‘Switch’ operation
Hypercyanotic spell
Introduction
• Sudden severe episodes of intense cyanosis caused by reduction of
pulmonary flow in patients with underlying Tetralogy of Fallot or other
cyanotic heart lesions.
• This is due to spasm of the right ventricular outflow tract or reduction in
systemic vascular resistance (e.g. hypovolaemia) with resulting increased in
right to left shunt across the VSD.
Clinical Presentation
• Peak incidence age: 3 to 6 months.
• Often in the morning, can be precipitated by crying,
feeding, defaecation.
• Severe cyanosis, hyperpnoea, metabolic acidosis.
• In severe cases, may lead to syncope, seizure, stroke or
death.
Acute management
1. Knee-chest/squatting position
2. Give IV/IM/SC morphine 0.1 – 0.2 mg/kg
If the above measures fail:
1. Give IV Propranolol 0.05 – 0.1 mg/kg slow bolus over 10 mins.
2. Alternatively, IV Esmolol 0.5 mg/kg slow bolus over 1 min, followed by 0.05
mg/kg/min for 4 mins.
3. Volume expander (crystalloid or colloid) 20 ml/kg rapid IV push to increase
preload.
4. Give IV sodium bicarbonate 1 – 2 mEq/kg to correct metabolic acidosis.
5. Heavy sedation, intubation and mechanical ventilation.
Acute management
In resistant cases, consider
• IV Phenylephrine (0.01 – 0.02 mg/kg slow bolus)
• or Noradrenaline infusion (0.1 – 0.5 mcg/kg/min)
• Emergency Blalock Taussig shunt.
Notes:
• A single episode of hypercyanotic spell is an indication for early surgical referral (either total
repair or Blalock Taussig shunt).
• Oral propranolol 0.2 – 1 mg/kg/dose 8 to 12 hourly should be started soon after stabilization
while waiting for surgical intervention.
Acquired Heart Disease
Contents
• Rheumatic fever
• Infective endocarditis
• Kawasaki disease
Rheumatic Fever
• Rare in the developed world but remains the most
important cause of heart disease in children
worldwide.
• Acute rheumatic fever is a short-lived, multisystem
autoimmune response to a preceding infection with
group A beta-haemolytic streptococcus.
• The disease mainly affects children aged 5-15 years.
• It progresses to chronic rheumatic heart disease in up
to 80% of cases.
Clinical features
• After a latent interval of 2-6 weeks following a
pharyngeal or skin infection, polyarthritis, mild
fever and malaise develop.
• Making the diagnosis (Jones Criteria)
[ 2 major criteria or 1 major + 2 minor
criteria + evidence of a preceding group A
streptococcal infection]
Treatment
•Aim to suppress inflammatory response so as to minimize cardiac
damage, provide symptomatic relief and eradicate pharyngeal
streptococcal infection.
• Bed rest. Restrict activity until acute phase reactants return to normal.
• Anti-streptococcal therapy:
- IV C. Penicillin 50000U/kg/dose 6H or Oral Penicillin V 250mg 6H
(<30kg), 500mg 6H (>30kg) for 10 days
- Oral Erythromycin for 10 days if allergic to penicillin.
• Anti-inflammatory therapy
- Mild/ no carditis (Oral aspirin 80-100mg/kg/day in 4 doses for 2-4
weeks, tapering over 4 weeks)
- Pericarditis, or moderate to severe carditis (Oral Prednisolone 2
mg/kg/day in 2 divided doses for 2-4 weeks, taper with addition of
aspirin as above.
• Anti-failure medications
- Diuretics, ACE inhibitors, digoxin (to be used with
caution)
**Consider early referral to a Paediatric cardiologist if
heart failure persists or worsens during the acute phase
despite aggressive medical therapy. Surgery may be
indicated.
• Secondary prophylaxis of rheumatic fever
- IM Benzathine Penicillin 0.6 mega unit (<30kg) or 1.2
mega units (>30kg) every 3 to 4 weeks.
- Oral Penicillin V 250mg twice daily.
- Oral Erythromycin 250mg twice daily if allergic to
Penicillin.
• Duration of prophylaxis
- Until age 21 years or 5 years after last attack of ARF
whichever was longer.
- Lifelong for patients with carditis and valvular
involvement.
Infective
Endocarditis
Definition – Risk factors
Is an infection of the endocardial surface of the heart which
frequently involves the heart valves
• Highest risk when there is a turbulent jet of blood:
• VSD
• Coarctation of the aorta
• PDA
• Insertion of prosthetic materials
Strep Viridans:
• Principal cause in
children with congenital
heart conditions without
previous history of
surgery.
Staph Aureus and CONS:
• Especially following
cardiac surgery and in
the presence of
prosthetic cardiac and
endovascular materials.
Candida:
• Especially in premature
infants with central
venous catheter / on
parenteral nutrition
Pathogenesis
Turbulent blood
flow
Endothelial damage
Lesion can be infected
Vegetation, usually occurring on
valve leaflet
-Immune complex formation
-mobilization of vegetation
-destruction of infected valve
Presence of transient
bacteremia
Clinical Signs
• Fever
• Anemia
• Splinter hemorrhages
• Clubbing (late)
• Necrotic skin lesions
• Changing cardiac signs
• Splenomegaly
• Retinal infarcts
• Hematuria (microscopic)
Pre-existing risk factors
•Congenital heart disease; whether unrepaired or repaired
•Prosthetic heart valves and intracardiac devices
•Previous history of infective endocarditis
•Native valvular heart diseases such as rheumatic heart disease
•Presence of chronic intravenous access such as indwelling
central venous catheters, chemoports and haemodialysis
catheters
•Immunocompromised patients
Investigation
•The diagnosis of IE requires combination of clinical features,
microbiological findings and identification of endocardial
involvements and extracardiac complications by imaging
tools.
Blood cultures
•Remains the cornerstone of diagnosis of IE
•At least 3 sets (to increase yield and reduce false positive rate by
skin contaminants)
•There is no necessity to wait for spikes of fever (due to continuous
nature of bacteraemia)
•Should be taken at 30 mins intervals between samples
•Should be obtained from peripheral veins and not from central
venous catheter using aseptic technique
•Should be taken before commencement of antibiotics
• Each set should include 1 aerobic and 1 anaerobic bottle with
minimal of 3 ml of blood
Echocardiography
• Findings suggestive of IE include vegetation, abscess,
pseudoaneurysm, new dehiscence of prosthetic valve, fistula, valve
leaflet perforation and aneurysm
• If clinical suspicion of IE remains high despite an initial negative
TTE, a repeat TTE or transoesophageal echocardiogram (TEE) is
recommended within a week
• TEE is advisable in cases with prosthetic valves, prosthetic cardiac
material and those with poor TTE acoustic window
• TTE is recommended at completion of antibiotic treatment to
assess treatment response
Modified Duke Criteria
Management
General principles:
•Use bactericidal instead of bacteriostatic agents
• Initial high dose parenteral route to achieve high bactericidal
effects
• Adequate duration to ensure complete eradication (4 to 6 weeks)
Surgical Intervention
Surgical intervention is indicated in the following cases:
• Heart failure: severe valvular regurgitation, obstruction or fistula
causing refractory pulmonary oedema, cardiogenic shock or severe
heart failure symptoms.
• Uncontrolled infection: infection caused by fungi, local extension of
infection (abscess, pseudoaneurysm, fistula, enlarging vegetation),
persistent positive blood cultures despite appropriate antibiotic therapy
and prosthetic valve endocarditis caused by staphylococci or non-
HACEK gram-negative bacteria.
• Prevention of embolism: Left-sided vegetation > 10 mm after 1 or
more embolic episode, very large vegetation > 30 mm.
Prophylaxis
The most important factor in prophylaxis against
endocarditis is good dental hygiene that should
be strongly encouraged in all children with
congenital heart disease along with avoidance of
body piercing and tattoos.
• dental treatment, however, trivial
• surgery which is likely to be associated with
bacteraemia.
KAWASAKI DISEASE
INTRODUCTION
• Kawasaki disease is a systemic vasculitis that predominantly affects
the medium size arteries ( most common: coronary artery)
• IMPORTANT DIAGNOSIS to make because aneurysms of the
coronary arteries are a potentially devastating complication
• Age: 6 months- 4 years ( peaks at the 1st year)
• Young infants are more severely affected than older children (
tend to not have all the cardinal features present)
• Specific cause is unknown, likely to be the result of immune
hyperactivity to a variety of triggers in a genetically susceptible
host
INTRODUCTION
• NO DIAGNOSTIC TEST, IT IS A CLINCAL DIAGNOSIS
PATHOGENESIS
• 3 phase process
Neutrophilic necrotizing arteritis
Begins in the endothelium and moves through the
coronary wall
Saccular aneurysms may form from this arteritis
( first 2 weeks)
Subacute/ chronic vasculitis driven by lymphocytes,
plasma cells and eosinophils
( lasts for weeks to years)
Smooth muscle cell myofibroblasts develops which causes
progressive stenosis.
Thrombi may form in the lumen and obstruct blood flow
stenosi
s
CLINICAL FEATURES
Bilateral, non-purulent
conjunctivitis
(beginning
periungually)
(usually truncal)
Unremitting and unresponsive
to antibiotics
CLINICAL FEATURES
Clinical phases
Acute febrile
phase
Characterized by fever and the other acute signs of illness and usually
lasts 1-2 weeks
Subacute phase Associated with desquamation, thrombocytosis, the development of CAA,
highest risk of sudden death in whom aneurysms have developed, lasts
about 3 weeks
Convalescent
phase
When all clinical signs have disappeared and continues until ESR returns
to normal, about 6-8 weeks after the onset of illness
CLINICAL FEATURES
Bilateral, non-purulent
conjunctivitis
Strawberry tongue
Polymorphous rash- can be
macular, maculopapular,
but NEVER vesicular
CLINICAL FEATURES
Periungual
desquamation
CLINICAL FEATURES
Diagnosis
Kawasaki disease Fever + 4/5 of the above symptoms
Incomplete Kawasaki disease Prolonged unexplained fever in an infant/ child
< 4 of the symptoms
Atypical Kawasaki disease Present atypically: eg: with renal impairment
CLINICAL FEATURES
• Other helpful signs are:
- Irritability/ altered mental state, aseptic
meningitis
- Erythema/ induration at the BCG site
- Perianal excoriation
- Transient arthritis
- Diarrhoea, vomiting, abdominal pain
- Hepatosplenomegaly
- Hydrops of gallbladder
- Sterile pyuria
COMPLICATIONS
• Coronary vasculitis ( usually within 2 weeks of illness, affecting
up to 25% of untreated children)
• MI
• Pericarditis
• Myocarditis
• Endocarditis
• Heart failure
• Arrhythmia
INVESTIGATIONS
• Lab investigations
- FBC ( anemia, leucocytosis, thrombocytosis )
- Albumin levels < 3g/dL
- Raised alanine aminotransferase
- Urine > 10 wbc/hpf (normal= 0-5)
INVESTIGATIONS
• Imaging
- Chest X-ray ( coronary artery calcification)
- ECG ( look for MI, pericarditis, arrhythmia)
- Echocardiogram ( look for heart failure, coronary artery
dilatation/ aneurysms)- do in the acute phase and repeat 6-8
weeks later
Echo indications ( with prolonged fever plus)
2 other criteria
Subsequent periungual desquamation
2 criteria + thrombocytosis
Rash without any other explaination
MANAGEMENT
PRIMARY TREATMENT
- IV immunoglobulin 2g/kg infusion
over 10-12 hours ( if therapy is
started < 10 days of onset of the
disease it is effective in preventing
coronary vascular damage)
- Oral aspirin ( anti-inflammatory
dose ) 30-50mg/kg/day in 3 divided
doses till day 14 of illness or until
patient is afebrile for 2-3 days
NOT RESPONDING TO PRIMARY
TREATMENT
- Repeat IVIG 2g/kg over 10-12 hours
Persistent fever > 36
hours after completion of
initial dose of IVIG
MANAGEMENT
MAINTENANCE
- Oral aspirin ( anti platelet dose)
3-5mg/kg daily
- For 6- 8 weeks or until ESR and
platelet count normalizes
- If coronary aneurysm is present,
then continue aspirin until resolved
Delay live vaccination for 11
months as the use of IVIG may
impair efficacy
Common heart conditions in children copy.pptx

More Related Content

What's hot

Congestive heart failure patnaik sir
Congestive heart failure patnaik sirCongestive heart failure patnaik sir
Congestive heart failure patnaik sirRamachandra Barik
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
Hussein Al-tameemi
 
Child with cardiovascular disorder
Child with cardiovascular disorderChild with cardiovascular disorder
Child with cardiovascular disorder
HI HI
 
Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)
Richard Brown
 
Heart failure in childhood
Heart failure in childhoodHeart failure in childhood
Heart failure in childhood
Reyad Al_Faky
 
Neurogenic shock
Neurogenic shockNeurogenic shock
Neurogenic shock
skrentz
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
Diana Prasad
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
Mintu Kottamkuzhiyil
 
Chronic Stable Angina
Chronic Stable AnginaChronic Stable Angina
Chronic Stable Angina
DJ CrissCross
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
Zahra Khan
 
Management of head injury
Management of head injuryManagement of head injury
Management of head injuryfyndoc
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Farhan Ali
 
Valvular heart disease for post graduates
Valvular heart disease for post graduates Valvular heart disease for post graduates
Valvular heart disease for post graduates
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Management of congenital heart disease in infants
Management of congenital heart disease in infantsManagement of congenital heart disease in infants
Management of congenital heart disease in infants
SMSRAZA
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aorta
Amrutha Ramakrishnan Nair
 
Syncope
Syncope  Syncope
Syncope SMSRAZA
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
yuyuricci
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseases
Dilmo Yeldo
 
Heart failure
Heart failureHeart failure
Heart failure
Tsegaye Melaku
 

What's hot (20)

Congestive heart failure patnaik sir
Congestive heart failure patnaik sirCongestive heart failure patnaik sir
Congestive heart failure patnaik sir
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Child with cardiovascular disorder
Child with cardiovascular disorderChild with cardiovascular disorder
Child with cardiovascular disorder
 
Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)
 
Heart failure in childhood
Heart failure in childhoodHeart failure in childhood
Heart failure in childhood
 
Neurogenic shock
Neurogenic shockNeurogenic shock
Neurogenic shock
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Chronic Stable Angina
Chronic Stable AnginaChronic Stable Angina
Chronic Stable Angina
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Management of head injury
Management of head injuryManagement of head injury
Management of head injury
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
coronary artery disease
coronary artery diseasecoronary artery disease
coronary artery disease
 
Valvular heart disease for post graduates
Valvular heart disease for post graduates Valvular heart disease for post graduates
Valvular heart disease for post graduates
 
Management of congenital heart disease in infants
Management of congenital heart disease in infantsManagement of congenital heart disease in infants
Management of congenital heart disease in infants
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aorta
 
Syncope
Syncope  Syncope
Syncope
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseases
 
Heart failure
Heart failureHeart failure
Heart failure
 

Similar to Common heart conditions in children copy.pptx

ACYANOTIC HEART DISEASE
ACYANOTIC HEART DISEASEACYANOTIC HEART DISEASE
ACYANOTIC HEART DISEASE
Sachin Gadade
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
supriya sharma
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
supriya sharma
 
Docslide:congenital heart disease
Docslide:congenital heart diseaseDocslide:congenital heart disease
Docslide:congenital heart diseasesiti hamidah
 
C.V.S.ppt
C.V.S.pptC.V.S.ppt
C.V.S.ppt
MpOnline7
 
Congenital Heart Disease
Congenital Heart DiseaseCongenital Heart Disease
Congenital Heart DiseaseJessie Madz
 
7.congenital heart dss
7.congenital heart dss7.congenital heart dss
7.congenital heart dss
Whiteraven68
 
Congenital h.d ..ppt
Congenital h.d ..pptCongenital h.d ..ppt
Congenital h.d ..ppt
AmritSharma65
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
Arifa T N
 
Congenital heart-disease
Congenital heart-diseaseCongenital heart-disease
Congenital heart-disease
DR .PALLAVI PATHANIA
 
Congenital heart-disease
Congenital heart-diseaseCongenital heart-disease
Congenital heart-disease
Bernard Katela
 
Acyanotic Heart Defects
Acyanotic Heart DefectsAcyanotic Heart Defects
Acyanotic Heart DefectsTosca Torres
 
4 nega Pediatrics cardiac-1.pptcccccccccccc
4 nega Pediatrics cardiac-1.pptcccccccccccc4 nega Pediatrics cardiac-1.pptcccccccccccc
4 nega Pediatrics cardiac-1.pptcccccccccccc
gedamudereje1
 
CHD.pptx
CHD.pptxCHD.pptx
CHD.pptx
poojaasokan1
 
Transposition of the great arteries
Transposition of the great arteriesTransposition of the great arteries
Transposition of the great arteries
jagan _jaggi
 
Congenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - RivinCongenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - Rivin
Rivindu Wickramanayake
 
Congenital Heart Defects
Congenital Heart DefectsCongenital Heart Defects
Congenital Heart Defectsdapinderjitgill
 
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
Azad Haleem
 
Congenital heart deseases by aslammatania
Congenital heart deseases by aslammataniaCongenital heart deseases by aslammatania
Congenital heart deseases by aslammatania
Aslam Matania
 

Similar to Common heart conditions in children copy.pptx (20)

ACYANOTIC HEART DISEASE
ACYANOTIC HEART DISEASEACYANOTIC HEART DISEASE
ACYANOTIC HEART DISEASE
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
 
Docslide:congenital heart disease
Docslide:congenital heart diseaseDocslide:congenital heart disease
Docslide:congenital heart disease
 
C.V.S.ppt
C.V.S.pptC.V.S.ppt
C.V.S.ppt
 
Congenital Heart Disease
Congenital Heart DiseaseCongenital Heart Disease
Congenital Heart Disease
 
7.congenital heart dss
7.congenital heart dss7.congenital heart dss
7.congenital heart dss
 
Congenital h.d ..ppt
Congenital h.d ..pptCongenital h.d ..ppt
Congenital h.d ..ppt
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
Congenital heart-disease
Congenital heart-diseaseCongenital heart-disease
Congenital heart-disease
 
Congenital heart-disease
Congenital heart-diseaseCongenital heart-disease
Congenital heart-disease
 
Acyanotic Heart Defects
Acyanotic Heart DefectsAcyanotic Heart Defects
Acyanotic Heart Defects
 
4 nega Pediatrics cardiac-1.pptcccccccccccc
4 nega Pediatrics cardiac-1.pptcccccccccccc4 nega Pediatrics cardiac-1.pptcccccccccccc
4 nega Pediatrics cardiac-1.pptcccccccccccc
 
CHD.pptx
CHD.pptxCHD.pptx
CHD.pptx
 
Transposition of the great arteries
Transposition of the great arteriesTransposition of the great arteries
Transposition of the great arteries
 
Congenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - RivinCongenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - Rivin
 
Congenital Heart Defects
Congenital Heart DefectsCongenital Heart Defects
Congenital Heart Defects
 
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
cyanotic and acyanotic Congenital heart disease for undergraduated student uo...
 
Congmal (1)
Congmal (1)Congmal (1)
Congmal (1)
 
Congenital heart deseases by aslammatania
Congenital heart deseases by aslammataniaCongenital heart deseases by aslammatania
Congenital heart deseases by aslammatania
 

Recently uploaded

NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
subedisuryaofficial
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 

Recently uploaded (20)

NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Citrus Greening Disease and its Management
Citrus Greening Disease and its ManagementCitrus Greening Disease and its Management
Citrus Greening Disease and its Management
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 

Common heart conditions in children copy.pptx

  • 1. Common Heart Conditons in Children Presenters: • Aqim • Analicia
  • 3. CONTENTS Fetal Circulation Congenital Heart Diseases (CHD) Incidence Mortality and Morbidity  Etiological Factors Classification of CHD Cyanotic Acyanotic Hemodynamics of Common CHD Assessment & Management
  • 5. Fetal Circulation Blood from placenta Inferior Vena Cava RightAtrium Left atrium via Foramen Ovale Left ventricle Aorta Head & Neck Returns via Superior Vena Cava RightAtrium Right Ventricle Pulmonary Artery Aorta via Patent Ductus Arteriosus Lower Extremities Blood to Placenta
  • 6. CONGENITAL HEART DISEASES (CHD) These are cardiac anomalies arising as a result of a defect in the structure or function of the heart and great vessels which is present at birth These lesions either obstruct blood flow in the heart or vessels near it, or alter the pathway of blood circulating through the heart
  • 7. CLASSIFICATION OF CHD ACYNOTIC Volume or Pressure Overload PDA, VSD,ASD, Coartation ofAorta PINK BABY CYNOTIC OR Pulmonary Blood flow Tetralogy of Fallot, Transposition of great vessels, TricuspidAtresia BLUE BABY
  • 8. Atrial Septal Defect (ASD)  An abnormal opening in the atrial septum which allows oxygenated blood from the left atrium to mix with deoxygenated blood in the right atrium at a minor pressure difference  Right atrium recieves blood from SVC,IVC as well as from left atrium leading to volume overload and pulmonary congestion  Occurs in about 4-10% of CHD  More common in female child
  • 9. Types of ASD:  Ostium Secundum most common- 50-70%, In the middle of the septum in the region of the foramen ovale  Ostium primum 30% -Low position Form of AV septal defect  Sinus venosus Least common-10% Site-at entry of superior venacava into right atrium
  • 10. Clinical Presentation: Most infants and children are asymptomatic but over years to decades may experience the symptoms depending on type and severity of ASD  Infant gets tired during feeding  Child gets tired with playing/eating  Shortness of breath  Fatigue  Sweating Palpitations Stunted growth
  • 11. Diagnosis: On Auscultation- S1 :normal S2: Widely split & fixed with P2 accentuated  Ejection systolic murmur is present
  • 12.  Chest X-ray - Mild to moderate cardiomegaly with enlarged right atrium & right ventricle, prominent pulmonary artery segment, increased pulmonary vascular markings
  • 13. Dr.Nidhi Ahya(Asst Prof)  ECG- Right Axis Deviation, Right ventricular strain pattern in lead V1  Echocardiogram- position, size, signs of LR shunt, flow
  • 14. Management:  20% of atrial septal defects will close spontaneously in the first year of life or as the child grows  For defects of 3-8mm, or smaller, supportive medical management – Digoxin, diuretics and prophylactic antibiotics are sufficient up till spontaneous closure  If defect is >8mm, surgical repair may be is required  If spontaneous closure does not occur by school- going age, surgical repair becomes essential to prevent lung problems that will develop from long- time exposure to extra blood flow  Surgical repair
  • 15.
  • 16. Ventricular Septal Defect (VSD)  An abnormal opening in the ventricular septum which allows oxygenated blood from the left ventricle to mix with deoxygenated blood in the right ventricle  Right ventricle recieves blood from right atrium as well as from left ventricle leading to volume overload and pulmonary congestion  VSDs are the most commonly occurring type of congenital heart defect, occurring in 14-17 % of babies born each year
  • 18. Types of VSD:  Supracristal VSD occurs just beneath the aortic valve at the left ventricular outflow tract  Membranous VSD The most common type and originate inferior to the crista supraventricularis  Muscular VSD Occur in the mid to apical interventricular septum
  • 19. Clinical Presentation:  Signs and symptoms vary with the size of the defect.  Clinical symptoms are usually not seen at birth because of continued high pulmonary vascular resistance in the newborn  Infants with moderate to large defects will become symptomatic within the first few weeks of life. Shortness of breath while feeding Poor growth Failure to gain weight Pounding Heart Frequent respiratory tract infections shunt occurs- cynosis, clubbing, If reversal of respiratory distress
  • 20. Diagnosis:  On Auscultation- Pansystolic murmur is present S1 is masked by the murmur S3 can be heard at the apex
  • 21. Chest X-ray- Cardiomegaly and incresed pulmonary vascular markings
  • 22. Management :  Medical management  digoxin Diuretics  Adequate nutrition high-calorie formula or breast milk supplemental tube feedings Prophylactic antibiotics to prevent bacterial endocarditis
  • 23.  Surgical repair – closed stitches or special patch  Interventional cardiac catheterization – Septal occluder  Outcome of Surgery- 95% success rate, growth of child catches up in 1-2 years, size of the heart reduces, murmurs can be heard 2-3 months post- operative also but hold very little clinical importance
  • 24. Patent Ductus Arteriosis (PDA)  Failure of closure of ductus arteriosus  Incidence: Mostly in premature infants or infants born to a mother who had rubella during the first trimester of pregnancy  Through the PDA -> oxygenated blood passes from the aorta to the pulmonary artery & mixes with the deoxygenated blood which goes to the lungs -> Increased blood volume to the lungs -> pulmonary hypertension and congestion
  • 25. Dr.Nidhi Ahya(Asst Prof)  As blood is pumped at high pressure through the PDA, the lining of the pulmonary artery will become irritated and inflamed. Bacteria in the bloodstream can easily infect this injured area bacterial endocarditis
  • 26. Clinical Presentation:  Shortness of breath  Congested breathing  Disinterest in feeding, or tiring while feeding  Poor weight gain  Sweating  Tachypnea  Bounding pulse
  • 27. Diagnosis:  On Auscultation- Continuous machinery murmur in the left infraclavicular region
  • 28.  Management: Medical Management •Indomethacin IV (prostaglandin inhibitor) may help close a PDA. It works by stimulating the muscles inside the PDA to constrict, thereby closing the connection •Digoxin •Diuretics Adequate nutrition • High-calorie formula or breast milk •Special nutritional supplements may be added to formula or pumped breast milk that increase the number of calories in each ounce
  • 29. Surgical Management •Repair is usually indicated in infants younger than 6 months of age who have large defects that are causing symptoms, such as poor weight gain and rapid breathing  Transcatheter coil closure of the PDA PDA ligation-involves closing the open PDAwith stitches or the vessel connecting the aorta and pulmonary artery may be cut and cauterized
  • 30. CYNOTIC HEART DISEASE These type of defects lead to either increased or decreased pulmonary blood flow The primary pathology arises either due to an obstructive lesion; or due to abnormal anatomy or both The shunt present is predominantly from Right to Left leading to shunting of venous blood without passing through the lungs to be oxygenated Unoxygenated blood circulates in arteries - > cyanosis Example: Tetralogy of Fallot,TGV
  • 31. Tetralogy of Fallot (TOF)  A complex condition of several congenital defects that occur due to abnormal devlopment of the fetal heart during the first 8 weeks of pregnancy  ‘Tetra’ meaning ‘four’ Ventricular septal defect (VSD) Pulmonary valve stenosis Overriding aorta Right ventricular hypertrophy
  • 32.
  • 33.  Due to pulmonary artery stenosis, RV has to work harder to push blood into the lungs, thereby increasing the RV pressure and size  Presence of VSD facilitates blood to pass from the RV into the left ventricle, and mixing of blood takes place.  Overriding of aorta- The aorta sits above both the left and right ventricles over the VSD, rather than just over the left ventricle. As a result, oxygen poor blood from the right ventricle can flow directly into the aorta instead of into the pulmonary artery to the lungs  Decresed pulmonary blood flow and poorly oxygenated blood circulating throughout the body leads to CYNOSIS
  • 34. Clinical Presentation: Cyanosis - (bluish color of the skin, lips, and nail beds) that occurs with such activity as crying or feeding  Irritability  Lethargic  Reduced physical activity  Fainting  Clubbing of nails of fingers/toes  Breathing difficulty
  • 35. Diagnosis: On Auscultation- An ejection systolic murmur is present at the Left parasternal region 3rd ICS due to pulmonary stenosis.
  • 36. Investigations Chest radiograph • Boot shaped heart • Unturned apex • Pulmonary artery bay • Oligemic lung fields • Enlarged aorta
  • 37. Investigations • ECG • RVH (p-pulmonale (Right atrium), tall R waves in V1, upright T wave in V1. • Marked right axis deviation • Echo • Detection of main features • Quantification of right ventricular outflow pressure gradient • May be performed with cardiac catheterization
  • 38. Management :  Requires surgical repair usually undertaken at 6-18 months age  It involves- closure of VSD with a tangential patch to correct the override and the pulmonary stenosis is relieved with a patch).
  • 39. Transposition of Great Vessels (TOG)  The aorta is connected to the right ventricle, and the pulmonary artery is connected to the left ventricle  Oxygen-poor (blue) blood returns to the right atrium from the body - > passes through the right atrium and ventricle, -> into the misconnected aorta back to the body.  Oxygen-rich (red) blood returns to the left atrium from the lungs - > passes through the left atrium and ventricle, -> into the pulmonary artery and back to the lungs.
  • 40.
  • 41. Clinical Presentation: Cyanosis - (bluish color of the skin, lips, and nail beds) that occurs with such activity as crying or feeding  Rapid and laboured breathing  Cold and clammy skin Failure to thrive
  • 42. Investigations • Echocardiography (confirmatory) • Chest radiograph 1. Egg on a string heart 2. Increased pulmonary vascular markings • ECG : normal
  • 43. Management:  Admitted to NICU  On ventilator support  Cardiac Catheterization  Ballon Atrial Septostomy  I.v. Prostaglandins administered  By 2nd week of life, TGA repair is done  ‘Switch’ operation
  • 45. Introduction • Sudden severe episodes of intense cyanosis caused by reduction of pulmonary flow in patients with underlying Tetralogy of Fallot or other cyanotic heart lesions. • This is due to spasm of the right ventricular outflow tract or reduction in systemic vascular resistance (e.g. hypovolaemia) with resulting increased in right to left shunt across the VSD.
  • 46. Clinical Presentation • Peak incidence age: 3 to 6 months. • Often in the morning, can be precipitated by crying, feeding, defaecation. • Severe cyanosis, hyperpnoea, metabolic acidosis. • In severe cases, may lead to syncope, seizure, stroke or death.
  • 47. Acute management 1. Knee-chest/squatting position 2. Give IV/IM/SC morphine 0.1 – 0.2 mg/kg If the above measures fail: 1. Give IV Propranolol 0.05 – 0.1 mg/kg slow bolus over 10 mins. 2. Alternatively, IV Esmolol 0.5 mg/kg slow bolus over 1 min, followed by 0.05 mg/kg/min for 4 mins. 3. Volume expander (crystalloid or colloid) 20 ml/kg rapid IV push to increase preload. 4. Give IV sodium bicarbonate 1 – 2 mEq/kg to correct metabolic acidosis. 5. Heavy sedation, intubation and mechanical ventilation.
  • 48. Acute management In resistant cases, consider • IV Phenylephrine (0.01 – 0.02 mg/kg slow bolus) • or Noradrenaline infusion (0.1 – 0.5 mcg/kg/min) • Emergency Blalock Taussig shunt. Notes: • A single episode of hypercyanotic spell is an indication for early surgical referral (either total repair or Blalock Taussig shunt). • Oral propranolol 0.2 – 1 mg/kg/dose 8 to 12 hourly should be started soon after stabilization while waiting for surgical intervention.
  • 50. Contents • Rheumatic fever • Infective endocarditis • Kawasaki disease
  • 51. Rheumatic Fever • Rare in the developed world but remains the most important cause of heart disease in children worldwide. • Acute rheumatic fever is a short-lived, multisystem autoimmune response to a preceding infection with group A beta-haemolytic streptococcus. • The disease mainly affects children aged 5-15 years. • It progresses to chronic rheumatic heart disease in up to 80% of cases.
  • 52. Clinical features • After a latent interval of 2-6 weeks following a pharyngeal or skin infection, polyarthritis, mild fever and malaise develop. • Making the diagnosis (Jones Criteria) [ 2 major criteria or 1 major + 2 minor criteria + evidence of a preceding group A streptococcal infection]
  • 53.
  • 54. Treatment •Aim to suppress inflammatory response so as to minimize cardiac damage, provide symptomatic relief and eradicate pharyngeal streptococcal infection. • Bed rest. Restrict activity until acute phase reactants return to normal. • Anti-streptococcal therapy: - IV C. Penicillin 50000U/kg/dose 6H or Oral Penicillin V 250mg 6H (<30kg), 500mg 6H (>30kg) for 10 days - Oral Erythromycin for 10 days if allergic to penicillin. • Anti-inflammatory therapy - Mild/ no carditis (Oral aspirin 80-100mg/kg/day in 4 doses for 2-4 weeks, tapering over 4 weeks) - Pericarditis, or moderate to severe carditis (Oral Prednisolone 2 mg/kg/day in 2 divided doses for 2-4 weeks, taper with addition of aspirin as above.
  • 55. • Anti-failure medications - Diuretics, ACE inhibitors, digoxin (to be used with caution) **Consider early referral to a Paediatric cardiologist if heart failure persists or worsens during the acute phase despite aggressive medical therapy. Surgery may be indicated. • Secondary prophylaxis of rheumatic fever - IM Benzathine Penicillin 0.6 mega unit (<30kg) or 1.2 mega units (>30kg) every 3 to 4 weeks. - Oral Penicillin V 250mg twice daily. - Oral Erythromycin 250mg twice daily if allergic to Penicillin. • Duration of prophylaxis - Until age 21 years or 5 years after last attack of ARF whichever was longer. - Lifelong for patients with carditis and valvular involvement.
  • 57. Definition – Risk factors Is an infection of the endocardial surface of the heart which frequently involves the heart valves • Highest risk when there is a turbulent jet of blood: • VSD • Coarctation of the aorta • PDA • Insertion of prosthetic materials
  • 58. Strep Viridans: • Principal cause in children with congenital heart conditions without previous history of surgery. Staph Aureus and CONS: • Especially following cardiac surgery and in the presence of prosthetic cardiac and endovascular materials. Candida: • Especially in premature infants with central venous catheter / on parenteral nutrition
  • 59. Pathogenesis Turbulent blood flow Endothelial damage Lesion can be infected Vegetation, usually occurring on valve leaflet -Immune complex formation -mobilization of vegetation -destruction of infected valve Presence of transient bacteremia
  • 60. Clinical Signs • Fever • Anemia • Splinter hemorrhages • Clubbing (late) • Necrotic skin lesions • Changing cardiac signs • Splenomegaly • Retinal infarcts • Hematuria (microscopic)
  • 61.
  • 62. Pre-existing risk factors •Congenital heart disease; whether unrepaired or repaired •Prosthetic heart valves and intracardiac devices •Previous history of infective endocarditis •Native valvular heart diseases such as rheumatic heart disease •Presence of chronic intravenous access such as indwelling central venous catheters, chemoports and haemodialysis catheters •Immunocompromised patients
  • 63. Investigation •The diagnosis of IE requires combination of clinical features, microbiological findings and identification of endocardial involvements and extracardiac complications by imaging tools.
  • 64. Blood cultures •Remains the cornerstone of diagnosis of IE •At least 3 sets (to increase yield and reduce false positive rate by skin contaminants) •There is no necessity to wait for spikes of fever (due to continuous nature of bacteraemia) •Should be taken at 30 mins intervals between samples •Should be obtained from peripheral veins and not from central venous catheter using aseptic technique •Should be taken before commencement of antibiotics • Each set should include 1 aerobic and 1 anaerobic bottle with minimal of 3 ml of blood
  • 65. Echocardiography • Findings suggestive of IE include vegetation, abscess, pseudoaneurysm, new dehiscence of prosthetic valve, fistula, valve leaflet perforation and aneurysm • If clinical suspicion of IE remains high despite an initial negative TTE, a repeat TTE or transoesophageal echocardiogram (TEE) is recommended within a week • TEE is advisable in cases with prosthetic valves, prosthetic cardiac material and those with poor TTE acoustic window • TTE is recommended at completion of antibiotic treatment to assess treatment response
  • 66.
  • 68.
  • 69.
  • 70. Management General principles: •Use bactericidal instead of bacteriostatic agents • Initial high dose parenteral route to achieve high bactericidal effects • Adequate duration to ensure complete eradication (4 to 6 weeks)
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78. Surgical Intervention Surgical intervention is indicated in the following cases: • Heart failure: severe valvular regurgitation, obstruction or fistula causing refractory pulmonary oedema, cardiogenic shock or severe heart failure symptoms. • Uncontrolled infection: infection caused by fungi, local extension of infection (abscess, pseudoaneurysm, fistula, enlarging vegetation), persistent positive blood cultures despite appropriate antibiotic therapy and prosthetic valve endocarditis caused by staphylococci or non- HACEK gram-negative bacteria. • Prevention of embolism: Left-sided vegetation > 10 mm after 1 or more embolic episode, very large vegetation > 30 mm.
  • 79. Prophylaxis The most important factor in prophylaxis against endocarditis is good dental hygiene that should be strongly encouraged in all children with congenital heart disease along with avoidance of body piercing and tattoos. • dental treatment, however, trivial • surgery which is likely to be associated with bacteraemia.
  • 81. INTRODUCTION • Kawasaki disease is a systemic vasculitis that predominantly affects the medium size arteries ( most common: coronary artery) • IMPORTANT DIAGNOSIS to make because aneurysms of the coronary arteries are a potentially devastating complication • Age: 6 months- 4 years ( peaks at the 1st year) • Young infants are more severely affected than older children ( tend to not have all the cardinal features present) • Specific cause is unknown, likely to be the result of immune hyperactivity to a variety of triggers in a genetically susceptible host
  • 82. INTRODUCTION • NO DIAGNOSTIC TEST, IT IS A CLINCAL DIAGNOSIS
  • 83. PATHOGENESIS • 3 phase process Neutrophilic necrotizing arteritis Begins in the endothelium and moves through the coronary wall Saccular aneurysms may form from this arteritis ( first 2 weeks) Subacute/ chronic vasculitis driven by lymphocytes, plasma cells and eosinophils ( lasts for weeks to years) Smooth muscle cell myofibroblasts develops which causes progressive stenosis. Thrombi may form in the lumen and obstruct blood flow stenosi s
  • 85. CLINICAL FEATURES Clinical phases Acute febrile phase Characterized by fever and the other acute signs of illness and usually lasts 1-2 weeks Subacute phase Associated with desquamation, thrombocytosis, the development of CAA, highest risk of sudden death in whom aneurysms have developed, lasts about 3 weeks Convalescent phase When all clinical signs have disappeared and continues until ESR returns to normal, about 6-8 weeks after the onset of illness
  • 86. CLINICAL FEATURES Bilateral, non-purulent conjunctivitis Strawberry tongue Polymorphous rash- can be macular, maculopapular, but NEVER vesicular
  • 88. CLINICAL FEATURES Diagnosis Kawasaki disease Fever + 4/5 of the above symptoms Incomplete Kawasaki disease Prolonged unexplained fever in an infant/ child < 4 of the symptoms Atypical Kawasaki disease Present atypically: eg: with renal impairment
  • 89. CLINICAL FEATURES • Other helpful signs are: - Irritability/ altered mental state, aseptic meningitis - Erythema/ induration at the BCG site - Perianal excoriation - Transient arthritis - Diarrhoea, vomiting, abdominal pain - Hepatosplenomegaly - Hydrops of gallbladder - Sterile pyuria
  • 90. COMPLICATIONS • Coronary vasculitis ( usually within 2 weeks of illness, affecting up to 25% of untreated children) • MI • Pericarditis • Myocarditis • Endocarditis • Heart failure • Arrhythmia
  • 91. INVESTIGATIONS • Lab investigations - FBC ( anemia, leucocytosis, thrombocytosis ) - Albumin levels < 3g/dL - Raised alanine aminotransferase - Urine > 10 wbc/hpf (normal= 0-5)
  • 92. INVESTIGATIONS • Imaging - Chest X-ray ( coronary artery calcification) - ECG ( look for MI, pericarditis, arrhythmia) - Echocardiogram ( look for heart failure, coronary artery dilatation/ aneurysms)- do in the acute phase and repeat 6-8 weeks later Echo indications ( with prolonged fever plus) 2 other criteria Subsequent periungual desquamation 2 criteria + thrombocytosis Rash without any other explaination
  • 93. MANAGEMENT PRIMARY TREATMENT - IV immunoglobulin 2g/kg infusion over 10-12 hours ( if therapy is started < 10 days of onset of the disease it is effective in preventing coronary vascular damage) - Oral aspirin ( anti-inflammatory dose ) 30-50mg/kg/day in 3 divided doses till day 14 of illness or until patient is afebrile for 2-3 days NOT RESPONDING TO PRIMARY TREATMENT - Repeat IVIG 2g/kg over 10-12 hours Persistent fever > 36 hours after completion of initial dose of IVIG
  • 94. MANAGEMENT MAINTENANCE - Oral aspirin ( anti platelet dose) 3-5mg/kg daily - For 6- 8 weeks or until ESR and platelet count normalizes - If coronary aneurysm is present, then continue aspirin until resolved Delay live vaccination for 11 months as the use of IVIG may impair efficacy